The European Commission has launched an initiative on the evaluation and revision of the general pharmaceutical legislation with an overall aim to ensure a future-proof and crisis-resistant regulatory system.
While putting severe pressure on healthcare systems worldwide and causing a global economic meltdown, the COVID-19 pandemic has created several challenges. One of the core ones is the question of responsibility for vaccination.
Reflecting and reporting on the impact of the new coronavirus on the ages-old obsessive (in)equality academia, media and others are swinging between claims that SARS-CoV-2 / COVID-19 (the pathogen / the disease) is either a blindfolded leveler or, on the contrary, a balance destroyer.
To stop the coronavirus, most countries ceased almost all economic and social activities. As a first response to prevent an exponential growth of cases, this was probably justified. However, we will not be able to bear the costs of such a complete shutdown for a very long time.
